26 insiders have filed at XRAY since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Campion Simon D | President, CEO | 239.8k | 0.12% | 2 buys $497k | |
| Scavilla Daniel T | President, CEO & Member Of Bod | 161.8k | 0.081% | ||
| Johnson Robert Anthony | SVP, Chief Supply Chain Office | 161.8k | 0.081% | ||
| Kraemer Harry M Jansen JR | Director | 148.4k | 0.074% | ||
| Frank Andreas G | Exec VP/Chief Business Officer | 119.9k | 0.06% | ||
| Lucier Gregory T | Director | 110.9k | 0.055% | 9 buys $1.9M | 1 sells $916k |
| Coleman Glenn | Executive VP & CFO | 89.8k | 0.045% | 1 buys $297k | |
| Rosenzweig Richard C | EVP, Corp Dev, Gc & Secretary | 85.2k | 0.043% | ||
| Frohning Andrea L. | SVP, Chro | 64.0k | 0.032% | ||
| Denti Aldo Mariano Roberto | EVP, Chief Commercial Officer | 59.5k | 0.03% | ||
| Brandt Eric | Director | 58.8k | 0.029% | ||
| Deese Willie A | Director | 57.7k | 0.029% | ||
| Varon Leslie F | Director | 57.5k | 0.029% | 1 buys $100k | |
| Holden Betsy D | Director | 54.6k | 0.027% | ||
| Vergis Janet S. | Director | 44.5k | 0.022% | ||
| Garth Matthew E | EVP & CFO | 44.0k | 0.022% | ||
| Czerney Kevin | VP, Chief Accounting Officer | 41.3k | 0.021% | ||
| Hosein Clyde | Director | 41.3k | 0.021% | ||
| Brackett Erania | SVP, Chief Marketing Officer | 39.9k | 0.02% | ||
| Gladden Brian T | Director | 29.0k | 0.015% | ||
| Mazelsky Jonathan Jay | Director | 28.8k | 0.014% | ||
| Barber Michael J | Director | 17.9k | <0.01% | ||
| Wenzel Ilse Dorothea | Director | 16.6k | <0.01% | ||
| Wagner Richard M | VP, Chief Accounting Officer | 11.1k | <0.01% | ||
| Forbes James D | Director | 10.0k | <0.01% | 2 buys $130k | |
| Zurbay Donald | Director | 6.9k | <0.01% |
Full register at boothcheck.com/insiders/XRAY. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.